Literature DB >> 26865099

Physicians' attitudes towards androgen replacement therapy for male and female sexual dysfunction.

L Lowenstein1, A Shechter2, H Porst3, F Tripodi4, Y Reisman5.   

Abstract

Androgen deficiency syndrome is a commonly diagnosed condition. The aim of this study was to investigate common clinical practices of specialists in the field of sexual medicine regarding androgen replacement treatment for men and women. Attendees of the 16th Annual Congress of the European Society of Sexual Medicine held in January 2014 in Istanbul, Turkey, were asked to participate in a survey during the congress days. A 24-item self-report, closed-question questionnaire was distributed. Three sections were accessed: sociodemographic data, professional background and personal practice patterns regarding androgen substitution in men and women. A total of 133 physicians (mean age 47 years; range 25-79) completed the survey. Responses were inconsistent regarding the lab tests used for primary evaluation of male androgen deficiency. The majority of participants (62%) recommended testosterone replacement therapy for symptomatic men with testosterone levels <8 nmol l(-1) (231 ng dl(-1)). Similarly, most physicians (88%) recognized a correlation between libido and testosterone levels in women. Only 42% and 53% reported they would prescribe testosterone to women with low libido, premenopausal and postmenopausal, respectively. This survey showed discrepancies among physicians regarding testosterone replacement therapy for men and women.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26865099     DOI: 10.1038/ijir.2016.2

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  20 in total

1.  Transversal European survey on testosterone deficiency diagnosis.

Authors:  Hermann M Behre; Sophie Christin-Maitre; Antonio Martin Morales; Jacques Tostain
Journal:  Aging Male       Date:  2012-03-01       Impact factor: 5.892

Review 2.  Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?

Authors:  Manthos G Giannoulis; Finbarr C Martin; K Sreekumaran Nair; A Margot Umpleby; Peter Sonksen
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

Review 3.  Hypogonadism, ED, metabolic syndrome and obesity: a pathological link supporting cardiovascular diseases.

Authors:  G Corona; E Mannucci; G Forti; M Maggi
Journal:  Int J Androl       Date:  2009-02-10

4.  Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging.

Authors:  S M Harman; E J Metter; J D Tobin; J Pearson; M R Blackman
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

5.  [French urologist's opinion on testosterone deficiency syndrome: Afu's andrology committee survey].

Authors:  J Tostain; C Coeuret
Journal:  Prog Urol       Date:  2008-08-27       Impact factor: 0.915

6.  Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study.

Authors:  Frederick C W Wu; Abdelouahid Tajar; Stephen R Pye; Alan J Silman; Joseph D Finn; Terence W O'Neill; Gyorgy Bartfai; Felipe Casanueva; Gianni Forti; Aleksander Giwercman; Ilpo T Huhtaniemi; Krzysztof Kula; Margus Punab; Steven Boonen; Dirk Vanderschueren
Journal:  J Clin Endocrinol Metab       Date:  2008-02-12       Impact factor: 5.958

7.  Prevalence of low sexual desire and hypoactive sexual desire disorder in a nationally representative sample of US women.

Authors:  Suzanne L West; Aimee A D'Aloisio; Robert P Agans; William D Kalsbeek; Natalie N Borisov; John M Thorp
Journal:  Arch Intern Med       Date:  2008-07-14

8.  Total testosterone and sex hormone-binding globulin are significantly associated with metabolic syndrome in middle-aged and elderly men.

Authors:  K-Y Chin; S Ima-Nirwana; I N Mohamed; A Aminuddin; W Z W Ngah
Journal:  Exp Clin Endocrinol Diabetes       Date:  2013-06-13       Impact factor: 2.949

9.  Prevalence of symptomatic androgen deficiency in men.

Authors:  Andre B Araujo; Gretchen R Esche; Varant Kupelian; Amy B O'Donnell; Thomas G Travison; Rachel E Williams; Richard V Clark; John B McKinlay
Journal:  J Clin Endocrinol Metab       Date:  2007-08-14       Impact factor: 5.958

Review 10.  Transdermal testosterone replacement therapy in men.

Authors:  M Iftekhar Ullah; Daniel M Riche; Christian A Koch
Journal:  Drug Des Devel Ther       Date:  2014-01-09       Impact factor: 4.162

View more
  1 in total

Review 1.  Transdermal Testosterone in Female Hypoactive Sexual Desire Disorder: A Rapid Qualitative Systematic Review Using Grading of Recommendations Assessment, Development and Evaluation.

Authors:  Kavitha Ganesan; Yacob Habboush; Senan Sultan
Journal:  Cureus       Date:  2018-03-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.